140 related articles for article (PubMed ID: 35405094)
1. Are Bacteria Just Bystanders in the Pathogenesis of Inflammatory Jaw Conditions?
He P; Francois K; Missaghian N; Le AD; Flynn TR; Shanti RM
J Oral Maxillofac Surg; 2022 Jun; 80(6):1094-1102. PubMed ID: 35405094
[TBL] [Abstract][Full Text] [Related]
2. Medication-related osteonecrosis of the jaw: Osteoclast profile in comparison with osteoradionecrosis of the jaw and osteomyelitis of the jaw.
Ngoc Thuy Tran V; Chaisuparat R
J Oral Pathol Med; 2021 Aug; 50(7):731-740. PubMed ID: 34038006
[TBL] [Abstract][Full Text] [Related]
3. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
[TBL] [Abstract][Full Text] [Related]
4. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Wehrhan F; Gross C; Creutzburg K; Amann K; Ries J; Kesting M; Geppert CI; Weber M
J Transl Med; 2019 Mar; 17(1):69. PubMed ID: 30832685
[TBL] [Abstract][Full Text] [Related]
5. Medication-related osteonecrosis of the jaw, osteoradionecrosis, and osteomyelitis: A comparative histopathological study.
De Antoni CC; Matsumoto MA; Silva AAD; Curi MM; Santiago Júnior JF; Sassi LM; Cardoso CL
Braz Oral Res; 2018; 32():e23. PubMed ID: 29723337
[TBL] [Abstract][Full Text] [Related]
6. Radiologic findings of osteonecrosis, osteoradionecrosis, osteomyelitis and jaw metastatic disease with cone beam CT.
Yfanti Z; Tetradis S; Nikitakis NG; Alexiou KE; Makris N; Angelopoulos C; Tsiklakis K
Eur J Radiol; 2023 Aug; 165():110916. PubMed ID: 37300936
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the histopathological characteristics of osteomyelitis, medication-related osteonecrosis of the jaw, and osteoradionecrosis.
Shuster A; Reiser V; Trejo L; Ianculovici C; Kleinman S; Kaplan I
Int J Oral Maxillofac Surg; 2019 Jan; 48(1):17-22. PubMed ID: 30054185
[TBL] [Abstract][Full Text] [Related]
8. Vascular Analysis of Soft Tissues Around the Bone Lesion in Osteoradionecrosis, Medication-Related Osteonecrosis, and Infectious Osteomyelitis of the Jaw.
Wang Z; Xu J; Wan J; Zhang W; Wang Y; Du Y
J Craniofac Surg; 2022 Oct; 33(7):e750-e754. PubMed ID: 36201691
[TBL] [Abstract][Full Text] [Related]
9. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):160-165. PubMed ID: 33180378
[TBL] [Abstract][Full Text] [Related]
10. Assessment of inflammatory jaw pathologies using bone SPECT/CT maximum standardized uptake value.
Toshima H; Ogura I
Dentomaxillofac Radiol; 2020 Dec; 49(8):20200043. PubMed ID: 32491931
[TBL] [Abstract][Full Text] [Related]
11. Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.
Kün-Darbois JD; Fauvel F
Morphologie; 2021 Jun; 105(349):170-187. PubMed ID: 33281055
[TBL] [Abstract][Full Text] [Related]
12. Bone Margin Analysis for Osteonecrosis and Osteomyelitis of the Jaws.
Qaisi M; Montague L
Oral Maxillofac Surg Clin North Am; 2017 Aug; 29(3):301-313. PubMed ID: 28709531
[TBL] [Abstract][Full Text] [Related]
13. A commentary on "Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral Maxillofac. Surg. 41 (2012) 283-289].
Kalmar JR
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):147-8. PubMed ID: 23107998
[No Abstract] [Full Text] [Related]
14. Response to - a commentary on "Suppurative osteomyelitis, bisphosphonate induced 1 osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its 2 implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral. Maxillofac. Surg. 41 (3) (2012) 283-289].
Marx RE; Tursun R
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):148-9. PubMed ID: 23219001
[No Abstract] [Full Text] [Related]
15. Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.
Akashi M; Wanifuchi S; Iwata E; Takeda D; Kusumoto J; Furudoi S; Komori T
Oral Maxillofac Surg; 2018 Mar; 22(1):59-63. PubMed ID: 29224060
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of osteomyelitis and osteonecrosis of the jaws and its etiologic implication of bisphosphonate in Asians.
Hong SO; Lee CY; Jung J; Kim DY; Walter C; Kwon YD
Clin Oral Investig; 2017 Jun; 21(5):1905-1911. PubMed ID: 27771829
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone may be a promising therapy for bisphosphonate-related osteonecrosis of jaw bones.
Li YF; Hu J
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):149-50. PubMed ID: 22763138
[No Abstract] [Full Text] [Related]
18. Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease.
Marx RE; Tursun R
Int J Oral Maxillofac Surg; 2012 Mar; 41(3):283-9. PubMed ID: 22244079
[TBL] [Abstract][Full Text] [Related]
19. Which symptoms negatively affect the oral health-related quality of life in patients with osteonecrosis of the jaw?
Sato T; Kusumoto J; Takeda D; Kishimoto M; Kashin M; Furudoi S; Akashi M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Aug; 130(2):175-180. PubMed ID: 32493679
[TBL] [Abstract][Full Text] [Related]
20. Comparison of maximum and mean standardized uptake values of jaw pathologies with bone SPECT/CT: an especial focus on medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
Nucl Med Commun; 2022 Dec; 43(12):1188-1194. PubMed ID: 36345763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
